What’s the problem?
In the inpatient setting, physicians face the cumbersome and time-consuming task of determining the most cost-effective anticoagulation medication for patients with newly discovered pulmonary embolism or deep vein thrombosis.
❝
Become a Huddle+ member below for full access to a detailed problem description, root cause and impact analyses, and three solutions to the problem.
